Search by Drug Name or NDC
NDC 72266-0247-01 Sodium Phenylacetate and Sodium Benzoate 100; 100 mg/mL; mg/mL Details
Sodium Phenylacetate and Sodium Benzoate 100; 100 mg/mL; mg/mL
Sodium Phenylacetate and Sodium Benzoate is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by FOSUN PHARMA USA INC. The primary component is SODIUM BENZOATE; SODIUM PHENYLACETATE.
Product Information
| NDC | 72266-0247 |
|---|---|
| Product ID | 72266-247_fc10509a-d2b2-5d1e-e053-6394a90ab0dd |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Sodium Phenylacetate and Sodium Benzoate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sodium Phenylacetate and Sodium Benzoate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100; 100 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | SODIUM BENZOATE; SODIUM PHENYLACETATE |
| Labeler Name | FOSUN PHARMA USA INC |
| Pharmaceutical Class | Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Nitrogen Binding Agent [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208521 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72266-0247-01 (72266024701)
| NDC Package Code | 72266-247-01 |
|---|---|
| Billing NDC | 72266024701 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (72266-247-01) / 50 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2022-08-18 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |